FTFinancial Times·2hBusiness
score+0.60
Incyte nears up to $2bn deal for blood disorder biotech Star
Original
Incyte nears up to $2bn deal for blood disorder biotech Star
“Acquisition language ('nears deal,' '$2bn') emphasizes growth and competitive positioning with optimistic market dynamics.”